Publication | Closed Access

Phase 1 clinical trial of adoptive immunotherapy using “off-the-shelf” activated natural killer cells in patients with refractory and relapsed acute myeloid leukemia

Hematological MalignancyCell TherapyMedicineAcute Myeloid LeukemiaHematologyTumor ImmunityImmunologyPhase 1Adoptive ImmunotherapyImmune Cell TherapyImmunotherapyOncologyCell TransplantationNatural Killer Cells